Akt activity in Alzheimer's disease and other neurodegenerative disorders

被引:150
|
作者
Rickle, A
Bogdanovic, N
Volkman, I
Winblad, B
Ravid, R
Cowburn, RF
机构
[1] KASPAC, Neurotec, Novum, S-14157 Huddinge, Sweden
[2] Netherlands Brain Bank, Amsterdam, Netherlands
关键词
Alzheimer's disease; Akt; apoptosis; IGF-I; post mortem brain;
D O I
10.1097/00001756-200404290-00005
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Enzyme activities of the serine/threonine kinase Akt were compared in mid-temporal and mid-frontal cortices from Alzheimer's disease cases and matched controls. Activities (GSK-3alpha/beta fusion protein phosphorylation by immunoprecipitated Akt) were significantly increased in temporal cortex soluble fractions from Alzheimer's disease compared with non-disease controls and positive disease controls with another neurodegenerative disease. Temporal cortex soluble fraction Akt activities positively correlated with Braak staging for neurofibrillary changes. Frontal cortex soluble fraction activities were significantly reduced in positive disease compared with Alzheimer's disease cases and non-disease controls. Strong Ser(473) Akt immunoreactivity was seen in Alzheimer's disease pyramidal neurons likely undergoing degeneration and in reactive astroglia. Non-disease and positive disease controls showed moderate Ser(473) Akt immunostaining of occasional pyramidal neurons.
引用
收藏
页码:955 / 959
页数:5
相关论文
共 50 条
  • [41] Inflammation and Brain Structure in Alzheimer’s Disease and Other Neurodegenerative Disorders: a Mendelian Randomization Study
    Wei-Shi Liu
    Ya-Ru Zhang
    Yi-Jun Ge
    Hui-Fu Wang
    Wei Cheng
    Jin-Tai Yu
    Molecular Neurobiology, 2024, 61 : 1593 - 1604
  • [42] Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
    Melanie D. Sweeney
    Abhay P. Sagare
    Berislav V. Zlokovic
    Nature Reviews Neurology, 2018, 14 : 133 - 150
  • [43] Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders
    Wang, Zheng-Yu
    Han, Zhen-Min
    Liu, Qi-Fei
    Tang, Wei
    Ye, Kui
    Yao, Yu-You
    INTERNATIONAL PSYCHOGERIATRICS, 2015, 27 (09) : 1429 - 1438
  • [44] Sirtuins as Novel Targets for Alzheimer's Disease and Other Neurodegenerative Disorders: Experimental and Genetic Evidence
    Albani, Diego
    Polito, Letizia
    Forloni, Gianluigi
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 19 (01) : 11 - 26
  • [45] Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders
    Shahim, Pashtun
    Blennow, Kaj
    Johansson, Per
    Svensson, Johan
    Lista, Simone
    Hampel, Harald
    Andersson, Leif Christer
    Zetterberg, Henrik
    NEUROMOLECULAR MEDICINE, 2017, 19 (01) : 154 - 160
  • [46] Protein aggregation in neurodegenerative disorders: Alzheimer's disease and Parkinson's disease
    Iwatsubo, T
    FRONTIERS OF THE MECHANISMS OF MEMORY AND DEMENTIA, 2000, (1200): : 137 - 138
  • [47] Metabolic Dysfunction in Alzheimer's Disease and Related Neurodegenerative Disorders
    Cai, Huan
    Cong, Wei-na
    Ji, Sunggoan
    Rothman, Sarah
    Maudsley, Stuart
    Martin, Bronwen
    CURRENT ALZHEIMER RESEARCH, 2012, 9 (01) : 5 - 17
  • [48] Biomarkers in saliva for Alzheimer's disease and other neurodegenerative diseases
    Fornitz, H. S. Gleerup
    Hogh, P.
    Hasselbalch, S. G.
    Simonsen, A. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 532 - 532
  • [49] Alzheimer's disease and other neurological disorders
    Henderson, V. W.
    CLIMACTERIC, 2007, 10 : 92 - 96
  • [50] Inhibition of tau phosphorylation: a new therapeutic strategy for the treatment of Alzheimer's disease and other neurodegenerative disorders
    Castro, A
    Martinez, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2000, 10 (10) : 1519 - 1527